| JOURNAL HOME | CME HOME | THIS MONTH | PAST ISSUES | ETOC | COLLECTIONS |
| AUTHORS | REVIEWERS | EDITORIAL BOARD | FEEDBACK | RSS | HELP |
| ||||||||||||||
| ||||||||||||||
|
|
|
|
||||||||||||
|
||||||||||||||
Departments of
*Cardiothoracic and Vascular Anesthesia and Intensive Care Medicine,
Cardiology, and
Cardiothoracic Surgery, University of Vienna, Vienna, Austria;
§Department of Anesthesia and Perioperative Care, University of California–San Francisco, San Francisco, California;
||Ludwig Boltzmann Institute for Clinical Anesthesia and Intensive Care, Vienna, Austria; and
¶Outcomes ResearchTM Group
Address correspondence to Dr. Angela Rajek, Department of Anesthesia and Intensive Care (C), Vienna General Hospital, University of Vienna, Wahringer Gurtel 18-20, Vienna A-1090, Austria. Address e-mail to maria.rajek{at}univie.ac.at
Heart transplantation in patients with increased pulmonary vascular resistance is often associated with postbypass right heart failure. We therefore compared the abilities of prostaglandin E1 (PGE1) and inhaled nitric oxide to reduce pulmonary vascular resistance during heart transplantation. Patients undergoing orthotopic heart transplantation for congestive heart failure were randomly assigned to either a PGE1 infusion at a rate of 8 ng · kg· -1min-1 starting 10 min before weaning from cardiopulmonary bypass (CPB) (n = 34) or inhalation of 4 ppm nitric oxide starting just before weaning from CPB (n = 34). Both treatments were increased stepwise, if necessary, and were stopped 6 h postoperatively. Hemodynamic values were recorded after the induction of anesthesia, 10 and 30 min after weaning from CPB, and 1 h and 6 h postoperatively. Immediately after weaning from CPB, pulmonary vascular resistance was nearly halved in the nitric oxide group but reduced by only 10% in the PGE1 group. Pulmonary artery pressure was decreased approximately 30% during nitric oxide inhalation, but only approximately 16% during the PGE1 infusion. Six hours after surgery, pulmonary vascular resistance and pulmonary artery pressure were similar in the two groups. The ratio between pulmonary vascular resistance and systemic vascular resistance was significantly less in the nitric oxide patients at all postbypass times. In contrast, the pulmonary-to-systemic vascular resistance ratio increased approximately 30% in the patients given PGE1. Cardiac output, heart rate, mean arterial pressure, right atrial pressure, and pulmonary wedge pressure did not differ between the groups. Weaning from CPB was successful in all patients assigned to nitric oxide inhalation; in contrast, weaning failed in six patients assigned to PGE1 (P = 0.03).
Implications: Nitric oxide inhalation selectively reduces pulmonary vascular resistance and pulmonary artery pressure immediately after heart transplantation which facilitates weaning from cardiopulmonary bypass.
This article has been cited by other articles:
|
|
 |
|
  Q. Zhao, Z. Liu, Z. Wang, C. Yang, J. Liu, and J. Lu Effect of Prepro-Calcitonin Gene-Related Peptide Expressing Endothelial Progenitor Cells on Pulmonary Hypertension Ann. Thorac. Surg., August 1, 2007; 84(2): 544 - 552. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Subramaniam and J.-P. Yared Management of Pulmonary Hypertension in the Operating Room Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2007; 11(2): 119 - 136. [Abstract] [PDF]
|
|
|
|
 |
|
 E. B. Lobato, T. Beaver, J. Muehlschlegel, D. S. Kirby, C. Klodell, and A. Sidi Treatment with phosphodiesterase inhibitors type III and V: milrinone and sildenafil is an effective combination during thromboxane-induced acute pulmonary hypertension Br. J. Anaesth., March 1, 2006; 96(3): 317 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kramm, B. Eberle, S. Guth, and E. Mayer Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy Eur. J. Cardiothorac. Surg., December 1, 2005; 28(6): 882 - 888. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Taghavi, A. Zuckermann, J. Ankersmit, G. Wieselthaler, A. Rajek, G. Laufer, E. Wolner, and M. Grimm Extracorporeal Membrane Oxygenation is Superior to Right Ventricular Assist Device for Acute Right Ventricular Failure After Heart Transplantation Ann. Thorac. Surg., November 1, 2004; 78(5): 1644 - 1649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Urdaneta, J. L. Willert, T. Beaver, B. Naik, D. S. Kirby, and E. B. Lobato Effects of a New Phosphodiesterase Enzyme Type V Inhibitor (UK 343-664) Versus Milrinone in a Porcine Model of Acute Pulmonary Hypertension Ann. Thorac. Surg., October 1, 2004; 78(4): 1433 - 1437. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Adhikari and J. T. Granton Inhaled Nitric Oxide for Acute Lung Injury: No Place for NO? JAMA, April 7, 2004; 291(13): 1629 - 1631. [Full Text] [PDF]
|
|
|
|
|
|
M. R. Bonnell, F. Urdaneta, D. S. Kirby, N. R. Valdez, T. M. Beaver, and E. B. Lobato Effects of sildenafil analogue UK 343-664 on a porcine model of acute pulmonary hypertension Ann. Thorac. Surg., January 1, 2004; 77(1): 238 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L.S. Vainikka, L. J. Heikkila, S. Kukkonen, and H. J. Toivonen Inhaled NO and prostacyclin during porcine single lung transplantation Ann. Thorac. Surg., December 1, 2001; 72(6): 1892 - 1897. [Abstract] [Full Text] [PDF]
|
|
|
